We demonstrated significant correlations of high expression levels of SPOCK1 in tumor tissues with advanced clinical stages, larger tumor sizes, lymph node and distal metastases, and worse prognoses in patients with ccRCC. This evidence concerns the gene SPOCK1 and neoplasm.